Coffin–Lowry syndrome

Coffin-Lowry syndrome (CLS) is a rare genetic disorder caused by pathogenic variants in the RPS6KA3 gene, which encodes the RSK2 protein kinase. It is inherited in an X-linked dominant pattern and is characterized by developmental delay, intellectual disability, distinctive facial features, and skeletal abnormalities, with the condition generally being more pronounced in males than in females.

The RPS6KA3 gene (ribosomal protein S6 kinase A3) is located on the X chromosome and encodes the RSK2 protein, a kinase involved in the MAPK/ERK signaling pathway. This pathway participates in signal transmission from the cell surface to the nucleus and regulates processes such as neuronal differentiation, synaptic plasticity, learning, memory, and the growth of different tissues. Pathogenic variants in RPS6KA3 reduce or abolish RSK2 function, altering essential signaling pathways during the development of the central nervous system and the skeleton. In hemizygous males, the disease typically results in moderate or severe intellectual disability and characteristic clinical features; in heterozygous females, expression is highly variable, ranging from mild forms to more overt manifestations, partly due to X chromosome inactivation. Most described cases are sporadic or de novo, although familial transmission can also occur. The estimated prevalence is low, around 1 in 40,000-50,000 males, with no clearly established ethnic predilection.

Symptoms

Signs usually become evident during childhood, as motor and language delay is observed. In males, intellectual disability, hypotonia, short stature, progressively more characteristic facial features, small hands with broad or tapered fingers, and skeletal anomalies such as kyphosis or scoliosis are frequent. Some patients present with stimulus-induced falling episodes, especially noise or startle, as well as seizures, auditory disturbances, sleep apnea, or cardiac complications. In females, the phenotype can be milder and more variable.

Disease management

There is no curative treatment for Coffin-Lowry syndrome, so management is symptomatic and multidisciplinary. Early intervention programs, physical therapy, occupational therapy, speech therapy, and individualized educational support are recommended. Seizures and drop attacks are treated according to their clinical presentation, and skeletal abnormalities, especially progressive scoliosis, require orthopedic monitoring and, in some cases, surgery. Cardiologic, auditory, respiratory, and developmental surveillance, as well as family genetic counseling, are also advised.

Genes analyzed

RPS6KA3 U
U Ultra Whole Genome Sequencing 30x

Bibliography

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy